Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy and business development for the firm. The details Rick Fair, the CEO and President of Bellicum, reported that they are thrilled to welcome a leader of Dr. Naeveā€™s caliber and […]

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) To Set-Up Manufacturing Facility For CAR-T Cell Therapy

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) is investing money in manufacturing facility to speed up the cell therapy clinical trials for use in curing cancer, just like rivals Juno Therapeutics and Kite Pharma. A 27,000 square feet space has been leased to build the CAR-T Therapy cells that will help cancer patients to develop a strong immunity. […]